-+ 0.00%
-+ 0.00%
-+ 0.00%

Natera To Present 12 Abstracts Highlights Of Signatera At 2025 San Antonio Breast Cancer Symposium

Benzinga·12/02/2025 13:01:17
Listen to the news

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that at least twelve abstracts highlighting Signatera will be shared at the 2025 San Antonio Breast Cancer Symposium (SABCS), taking place December 9-12.